Skye Bioscience EPS Basic from Tax Loss Carryforward (Quarterly) Analysis

Skye Bioscience, Inc. (SKYE)

0.9806 +0.01 (+0.79%) USD | NASDAQ | Jan 21, 16:00

0.9354 -0.05 (-4.61%) Pre-Market: 08:08

View EPS Basic from Tax Loss Carryforward (Quarterly) for SKYE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Perspective Therapeutics, Inc.	--
Theravance Biopharma, Inc.	--
Viking Therapeutics, Inc.	--
Kyntra Bio, Inc.	--
Myomo, Inc.	--